Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.875
+0.015 (0.81%)
At close: Sep 18, 2026, 4:00 PM EDT
1.922
+0.046 (2.48%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $217.66 million as of September 18, 2026. Its market cap has increased by 143.28% in one year.
Market Cap
217.66M
Enterprise Value
199.12M
1-Year Change
143.28%
Ranking
Category
Stock Price
$1.88
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $217.66M, an increase of 211.98%. That is a compound annual growth rate of 15.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 220.42M | 131.83% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 355.70M |
| Emergent BioSolutions | 346.10M |
| Anika Therapeutics | 278.90M |
| Akebia Therapeutics | 254.33M |
| Aurora Cannabis | 248.87M |
| SIGA Technologies | 222.73M |
| Journey Medical | 206.32M |
| Organogenesis Holdings | 178.86M |